Immunic, Inc.
IMUX
$0.8293
-$0.0229-2.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.85% | 1.56% | -7.37% | 24.60% | 24.94% |
| Total Depreciation and Amortization | 42.98% | 43.81% | 20.72% | 14.02% | 26.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -43.98% | -48.09% | 101.77% | -64.57% | -66.95% |
| Change in Net Operating Assets | -59.26% | -22.39% | -98.58% | -58.37% | -43.69% |
| Cash from Operations | -24.61% | -9.69% | -19.69% | -5.47% | -6.10% |
| Capital Expenditure | 67.62% | -7.28% | 20.96% | -153.57% | -113.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -100.00% |
| Cash from Investing | 67.62% | -106.84% | -102.79% | -42,500.00% | -1,300.00% |
| Total Debt Issued | -100.00% | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5,991.09% | -92.92% | -73.48% | -98.66% | -98.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -12.95% | -99.90% | 7,115.97% | 32.93% | 34.10% |
| Foreign Exchange rate Adjustments | 269.83% | -176.45% | -294.27% | -75.45% | -114.35% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,114.48% | -1,923.95% | 81.68% | 95.28% | 122.29% |